# Akang Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/akang-health

- Industry: Healthcare
- Headquarters: Guangzhou, China
- Total disclosed funding: $31M
- Latest round: Series B (Mar 16, 2021)
- Investors on record: 5

## About

Based in Guangzhou, China, and founded in 2016, Guangdong Akang Health Technology Group Co., Ltd., trading under the name Akang Health, provides chronic disease prescription drug operations and comprehensive pharmaceutical services for the healthcare industry. The company focuses on out-of-hospital care for chronic disease patients and assists pharmaceutical enterprises with channel expansion. In February 2026, the company closed a venture funding round from Green Finance Holding.

Akang Health is divided into three main business areas to realize the empowerment of the terminal's supply chain and disease management capabilities. The first business area is referred as “Cloud Drug Library”. It focuses on terminal supply chain services for chronic, severe, and rare diseases. The second business area is referred to as "Cloud Pharmacy", which provides B2C and C2C services that focus on online and offline pharmacy services to the customer side. The third business area mainly offers clinical treatment path disease solutions, data management for patients with chronic diseases, and related software.

The company generates revenue from B2B and B2C contracts through the sales of prescription drugs, as well as drug e-commerce operation and management service fees.

## Funding rounds

- Series B, Mar 16, 2021, $31M — China International Capital Corporation, China Science and Tech Innovation Venture Capital, Tzitzit Asset
- Series A, Sep 10, 2018 — GF Xinde Investment
- Angel, May 18, 2017 — GF Xinde Investment, GF Qianhe

## Investors

- GF Xinde Investment (https://capitalatlas.ai/funds/gf-xinde-investment) — Angel, Series A
- GF Qianhe — Angel
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series B
- China Science and Tech Innovation Venture Capital (https://capitalatlas.ai/funds/china-science-and-tech-innovation-venture-capital) — Series B
- Tzitzit Asset — Series B